Employer advocacy For those on employer-sponsored plans, talking to your HR department about adding weight management drug coverage can make a difference, especially if multiple employees are interested
Final Thoughts GLP-1 medications have transformed how we treat obesity: Semaglutide broke ground with ~15% average weight loss
According to a 2025 trial, the average weight loss by those using weight loss injections varied between 13.7% for semaglutide (Wegovy) and 20.2% for tirzepatide (Mounjaro)
This genome encodes 13 subunits of the complexes that constitute the electron transport chain (ETC), while the remaining subunits, along with other mitochondrial proteins, are encoded by nuclear DNA
Go YY, Ju WM, Lee CM, Chae SW, Song JJ